These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 270715

  • 21. Apolipoprotein C-II mimetic peptide is an efficient activator of lipoprotein lipase in human plasma as studied by a calorimetric approach.
    Reimund M, Wolska A, Risti R, Wilson S, Sviridov D, Remaley AT, Lookene A.
    Biochem Biophys Res Commun; 2019 Oct 29; 519(1):67-72. PubMed ID: 31477272
    [Abstract] [Full Text] [Related]

  • 22. Mechanism of action of lipoprotein lipase on triolein particles: effect of apolipoprotein C-II.
    Tajima S, Yokoyama S, Yamamoto A.
    J Biochem; 1984 Dec 29; 96(6):1753-67. PubMed ID: 6530395
    [Abstract] [Full Text] [Related]

  • 23. A Pressure-dependent Model for the Regulation of Lipoprotein Lipase by Apolipoprotein C-II.
    Meyers NL, Larsson M, Olivecrona G, Small DM.
    J Biol Chem; 2015 Jul 17; 290(29):18029-18044. PubMed ID: 26026161
    [Abstract] [Full Text] [Related]

  • 24. Fatty acyl chain specificity of phosphatidylcholine hydrolysis catalyzed by lipoprotein lipase. Effect of apolipoprotein C-II and its (56-79) synthetic fragment.
    McLean LR, Best S, Balasubramaniam A, Jackson RL.
    Biochim Biophys Acta; 1986 Oct 03; 878(3):446-9. PubMed ID: 3756205
    [Abstract] [Full Text] [Related]

  • 25. C-terminal domain of apolipoprotein CII as both activator and competitive inhibitor of lipoprotein lipase.
    Cheng Q, Blackett P, Jackson KW, McConathy WJ, Wang CS.
    Biochem J; 1990 Jul 15; 269(2):403-7. PubMed ID: 2386483
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Activation of lipoprotein lipase by apolipoprotein C-II is modulated by the COOH terminal region of apolipoprotein C-III.
    Catapano AL.
    Chem Phys Lipids; 1987 Oct 15; 45(1):39-47. PubMed ID: 3446410
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effects of sphingomyelin and cholesterol on lipoprotein lipase-mediated lipolysis in lipid emulsions.
    Arimoto I, Saito H, Kawashima Y, Miyajima K, Handa T.
    J Lipid Res; 1998 Jan 15; 39(1):143-51. PubMed ID: 9469593
    [Abstract] [Full Text] [Related]

  • 32. A novel apolipoprotein C-II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E-knockout mice.
    Amar MJ, Sakurai T, Sakurai-Ikuta A, Sviridov D, Freeman L, Ahsan L, Remaley AT.
    J Pharmacol Exp Ther; 2015 Feb 15; 352(2):227-35. PubMed ID: 25395590
    [Abstract] [Full Text] [Related]

  • 33. Characterization of recombinant wild type and site-directed mutations of apolipoprotein C-III: lipid binding, displacement of ApoE, and inhibition of lipoprotein lipase.
    Liu H, Talmud PJ, Lins L, Brasseur R, Olivecrona G, Peelman F, Vandekerckhove J, Rosseneu M, Labeur C.
    Biochemistry; 2000 Aug 08; 39(31):9201-12. PubMed ID: 10924113
    [Abstract] [Full Text] [Related]

  • 34. Activation of lipoprotein lipase by synthetic fragments of apolipoprotein C-II.
    Smith LC, Voyta JC, Catapano AL, Kinnunen PK, Gotto AM, Sparrow JT.
    Ann N Y Acad Sci; 1980 Aug 08; 348():213-23. PubMed ID: 6930927
    [No Abstract] [Full Text] [Related]

  • 35. Human plasma apolipoprotein C-II: total solid-phase synthesis and chemical and biological characterization.
    Fairwell T, Hospattankar AV, Brewer HB, Khan SA.
    Proc Natl Acad Sci U S A; 1987 Jul 08; 84(14):4796-800. PubMed ID: 3474626
    [Abstract] [Full Text] [Related]

  • 36. Lipolysis of ApoC-II deficient very low density lipoproteins: enhancement of lipoprotein lipase action by synthetic fragments of apoC-II.
    Catapano AL, Kinnunen PK, Breckenridge WC, Gotto AM, Jackson RL, Little JA, Smith LC, Sparrow JT.
    Biochem Biophys Res Commun; 1979 Aug 13; 89(3):951-7. PubMed ID: 226096
    [No Abstract] [Full Text] [Related]

  • 37. Lipoprotein lipase in rat heart--II. Influence of apolipoproteins and nutritional factors on tri-, di- and monoacylglycerol lipase activities in post-heparin effluents.
    Verine A, Benkirane M, Meignen JM, Boyer J.
    Comp Biochem Physiol B; 1989 Aug 13; 94(1):19-25. PubMed ID: 2598633
    [Abstract] [Full Text] [Related]

  • 38. Comparison of the triacylglycerol hydrolase activity of human post-heparin plasma lipoprotein lipase and hepatic triacylglycerol lipase. A monolayer study.
    Jackson RL, Ponce E, McLean LR, Demel RA.
    Biochemistry; 1986 Mar 11; 25(5):1166-70. PubMed ID: 3964663
    [Abstract] [Full Text] [Related]

  • 39. Physical, chemical and immunochemical characterization of a lipoprotein lipase activator protein from pig plasma very low density lipoproteins.
    Jackson RL, Chung BH, Smith LC, Taunton OD.
    Biochim Biophys Acta; 1977 Feb 22; 490(2):385-94. PubMed ID: 189830
    [Abstract] [Full Text] [Related]

  • 40. Chymotryptic cleavage of lipoprotein lipase. Identification of cleavage sites and functional studies of the truncated molecule.
    Lookene A, Bengtsson-Olivecrona G.
    Eur J Biochem; 1993 Apr 01; 213(1):185-94. PubMed ID: 8477692
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.